Daewoong Co., Ltd. (KRX:003090)

Market Cap	1.00T
Revenue (ttm)	1.97T
Net Income (ttm)	62.94B
Shares Out	40.89M
EPS (ttm)	1,539.39
PE Ratio	15.95
Forward PE	6.87
Dividend	200.00 (0.79%)
Ex-Dividend Date	Dec 27, 2024

Volume	97,313
Average Volume	205,073
Open	25,800
Previous Close	25,650
Day's Range	25,050 - 26,300
52-Week Range	17,420 - 28,850
Beta	1.00
RSI	46.25
Earnings Date	Aug 14, 2025

About Daewoong

Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1945 and is headquartered in Seongnam, South...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1945
• Employees: 356
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 003090

Financial Performance

In 2024, Daewoong's revenue was 1.94 trillion, an increase of 6.79% compared to the previous year's 1.81 trillion. Earnings were 57.89 billion, a decrease of -62.08%.